Study Finds NHS Chatbots May Deter Cervical Screening When Overly Pushy
Researchers at the University of Surrey found that AI chatbots used for NHS cervical screening appointments can discourage patients through excessive messaging and pushy reminders. The study examined how patients respond to different chatbot communication styles when booking screening appointments. The findings suggest that chatbot design significantly impacts patient engagement with preventive health services.
A University of Surrey study examining patient interactions with NHS chatbots for cervical screening appointments has identified key factors affecting patient willingness to book appointments. Researchers found that patients respond positively to friendly, choice-oriented language in chatbot communications, but are deterred by overmessaging, pushy reminders, and unclear boundaries between human and AI interactions. The research highlights the importance of thoughtful chatbot design in healthcare settings, where communication style can influence whether patients engage with preventive screening services. These findings have implications for how healthcare systems implement AI tools to support patient care and appointment booking.
What's missing
The study's sample size, methodology details, specific chatbot design variations tested, and whether findings apply to other screening types or healthcare contexts are not provided in the available excerpt.
What different sources said
- Medical XpressCenter
Pushy NHS chatbots risk putting patients off screening appointments, researchers warn
Related
FDA Updates Alli Label to Warn of Rare but Potentially Fatal Kidney Problems
The FDA has approved updated labeling for Alli, an over-the-counter weight loss pill, to warn of rare risks including acute kidney injury, kidney stones, and oxalate nephropathy. The agency now instructs people with kidney disease history to consult a doctor before use and directs all users to stop taking the drug if they experience symptoms like back pain, blood in urine, or leg swelling. This warning is significant because Alli is the only OTC weight loss medication available in the U.S., and approximately 40 million people have used orlistat (Alli's generic form) since its approval in 1999.
AI's Growing Role in Clinical Trials Depends on Skilled Implementation
Artificial intelligence is being integrated across clinical trials for drug discovery, patient selection, protocol design, and data management. The technology shows particular promise for rare disease research through AI-powered artificial twins that could replace traditional placebo controls. However, experts emphasize that AI tools are only effective when properly implemented by trained personnel who prioritize patient outcomes over technological advancement.
US Suicide Deaths Fall Nationally, but Several States See Sharp Increases
National suicide deaths fell 3% between 2023-2024, but New Hampshire experienced a 12% increase, with Iowa, Connecticut, and South Carolina also seeing double-digit or near double-digit rises. The report from Trust for America's Health notes that rural areas tend to have higher suicide rates, though the specific causes of state-level variations remain unclear. Regional disparities persist, with the Midwest showing the highest suicide rates and the Northeast the lowest, though all regions have increased substantially since 2004.